Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viens

Showing results (101-110 of 244) with videos related to

Pageof 25
Sort By:
Pathologie-Biologie|December 29, 2004
[Is oral chemotherapy an alternative to IV chemotherapy in aged patients?]A C Braud, F Retornaz, C Dupuis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 13, 2006
Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinomaG Houvenaeghel, L Lelievre, M Buttarelli, et al.
Transplantation|February 15, 1996
Bone marrow and blood cells as alternative sources of hematopoietic progenitors after failure of a first collection. A single institution retrospective studyT Aurran-Schleinitz, C Chabannon, C Faucher, et al.
British Journal of Cancer|February 1, 1989
5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancerJ Santini, G Milano, A Thyss, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term resultsF Bertucci, P Viens, J R Delpero, et al.
Bone Marrow Transplantation|July 1, 1990
Mixed chimerism after allogeneic bone marrow transplantation for leukemiasM F Bertheas, M Lafage, D Blaise, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 30, 1998
[Local recurrences after conservative treatment of breast cancer: risk factors and influence on survival]D Cowen, G Houvenaeghel, J Jacquemier, et al.
Health and Quality of Life Outcomes|April 22, 2024
Construction and preliminary validation of a tool to measure the needs of adolescents and young adults (AYA) diagnosed with cancer: the QUestionnaire nEEd Cancer AYAs: QUEEC-AYAsS Justafré, P Marino, R Touzani, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-upD Cowen, J Jacquemier, G Houvenaeghel, et al.
Anticancer Research|November 1, 1994
Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expressionJ Jacquemier, F Penault-Llorca, P Viens, et al.
Pageof 25

Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Pathologie-Biologie|December 29, 2004
[Is oral chemotherapy an alternative to IV chemotherapy in aged patients?]A C Braud, F Retornaz, C Dupuis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 13, 2006
Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinomaG Houvenaeghel, L Lelievre, M Buttarelli, et al.
Transplantation|February 15, 1996
Bone marrow and blood cells as alternative sources of hematopoietic progenitors after failure of a first collection. A single institution retrospective studyT Aurran-Schleinitz, C Chabannon, C Faucher, et al.
British Journal of Cancer|February 1, 1989
5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancerJ Santini, G Milano, A Thyss, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term resultsF Bertucci, P Viens, J R Delpero, et al.
Bone Marrow Transplantation|July 1, 1990
Mixed chimerism after allogeneic bone marrow transplantation for leukemiasM F Bertheas, M Lafage, D Blaise, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 30, 1998
[Local recurrences after conservative treatment of breast cancer: risk factors and influence on survival]D Cowen, G Houvenaeghel, J Jacquemier, et al.
Health and Quality of Life Outcomes|April 22, 2024
Construction and preliminary validation of a tool to measure the needs of adolescents and young adults (AYA) diagnosed with cancer: the QUestionnaire nEEd Cancer AYAs: QUEEC-AYAsS Justafré, P Marino, R Touzani, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-upD Cowen, J Jacquemier, G Houvenaeghel, et al.
Anticancer Research|November 1, 1994
Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expressionJ Jacquemier, F Penault-Llorca, P Viens, et al.
Pageof 25